Biotech Archives - Page 76 of 89 - Boston Life Sciences Times

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

April 22, 2026

THIS WEEK'S STORIES

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

April 27, 2026

Beth Israel Lahey Health Expands AI Scribing Tool to All Physicians After Successful Trial

April 28, 2026

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

April 29, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

4Moving Biotech Secures FDA Fast Track Status for Experimental Knee Osteoarthritis Drug

PureTech Reports Promising Early Trial Results for Blood Cancer Therapy

Most Read

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

Strand Therapeutics Names Kunal Bhatia Chief Financial Officer

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

Axoft Raises $55 Million to Expand Brain-Computer Interface Trials and Manufacturing

EDITOR PICKS

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

THIS WEEK'S STORIES

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

Beth Israel Lahey Health Expands AI Scribing Tool to All Physicians After Successful Trial

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

POPULAR CATEGORY

ABOUT US

FOLLOW US